文献速递慢性肾脏病

慢性肾脏病中估算GFR与白蛋白尿的生物学变异度

Biological Variability of Estimated GFR and Albuminuria in CKD.
PubMed 文献 · Am J Kidney Dis · 2018-07-18

本研究在50例临床稳定的慢性肾脏病门诊患者中,于不足4周内重复采集样本,评估估算GFR标志物与白蛋白尿的短期个体内变异度。结果显示滤过标志物的个体内变异系数较低,而白蛋白尿的变异度很高,提示随机变异与有意义的生物学变化难以区分。

要点

  • 血清肌酐、胱抑素C等滤过标志物的短期个体内变异度较低。
  • 白蛋白尿(UAC、UACR)的短期个体内变异度很高,需谨慎解读变化。
  • 临床判断eGFR或白蛋白尿变化时需考虑个体内变异度。

核心结论

  • eGFR标志物短期个体内变异度相对较低,而白蛋白尿变异度较高,难以区分随机变异与有意义的生物学变化。

研究设计与样本

  • 横断面研究,在不足4周内对50例临床稳定的慢性肾脏病门诊患者进行3次访视的重复采样测量。

主要发现

  • 滤过标志物中位个体内变异系数(CVw)及参考变化值(RCVpos;RCVneg):血清肌酐5.4%(+16%;-14%),胱抑素C 4.1%(+12%;-11%),BTP 7.4%(+23%;-18%),B2M 5.6%(+17%;-14%)。
  • 白蛋白尿中位CVw及RCV:晨尿UAC 33.2%(+145%;-59%),随机尿UAC 50.6%(+276%;-73%),晨尿UACR 32.5%(+141%;-58%),随机尿UACR 29.7%(+124%;-55%)。
  • 滤过标志物的CVw在基线eGFR范围内可比,UAC和UACR的CVw在基线白蛋白尿范围内可比。

临床怎么用

  • 解读慢性肾脏病患者eGFR或白蛋白尿变化时,应结合短期个体内变异度判断临床意义。
  • 白蛋白尿的高变异度提示单次测量变化可能为随机波动,需重复检测确认。

局限性

  • 样本量小,限制了对不同标志物间变异度差异的检测能力。
  • 患者在临床而非研究环境中招募和随访,部分分析前因素无法控制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Determining whether a change in estimated glomerular filtration rate (eGFR) or albuminuria is clinically significant requires knowledge of short-term within-person variability of the measurements, which few studies have addressed in the setting of chronic kidney disease. STUDY DESIGN: Cross-sectional study with multiple collections over less than 4 weeks. SETTING & PARTICIPANTS: Clinically stable outpatients with chronic kidney disease (N=50; mean age, 56.8 years; median eGFR, 40mL/min/1.73m2; median urinary albumin-creatinine ratio (UACR), 173mg/g). EXPOSURE: Repeat measurements from serially collected samples across 3 study visits. OUTCOMES: Measurements of urine albumin concentration (UAC), UACR, and plasma creatinine, cystatin C, β2-microglobulin (B2M), and beta trace protein (BTP). ANALYTICAL APPROACH: We calculated within-person coefficients of variation (CVw) values and corresponding reference change positive and negative (RCVpos and RCVneg) values using log-transformed measurements. RESULTS: Median CVw (RCVpos; RCVneg) values of filtration markers were 5.4% (+16%; -14%) for serum creatinine, 4.1% (+12%; -11%) for cystatin C, 7.4% (+23%; -18%) for BTP, and 5.6% (+17%; -14%) for B2M. Results for albuminuria were 33.2% (+145%; -59%) for first-morning UAC, 50.6% (+276%; -73%) for random spot UAC, 32.5% (+141%; -58%) for first-morning UACR, and 29.7% (124%; -55%) for random spot UACR. CVw values for filtration markers were comparable across the range of baseline eGFRs. CVw values for UAC and UACR were comparable across the range of baseline albuminuria values. LIMITATIONS: Small sample size limits the ability to detect differences in variability across markers. Participants were recruited and followed up in a clinical and not research setting, so some preanalytical factors could not be controlled. CONCLUSIONS: eGFR markers appear to have relatively low short-term within-person variability, whereas variability in albuminuria appears to be high, making it difficult to distinguish random variability from meaningful biologic changes.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Waikar SS, Rebholz CM, Zheng Z, et al. Biological Variability of Estimated GFR and Albuminuria in CKD. Am J Kidney Dis. 2018. PMID: 30031564. doi:10.1053/j.ajkd.2018.04.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。